Connect with us

Ludiomil (maprotiline)

Maprotiline (or LUDIOMIL®) is mainly prescribed to treat depressive disorderspanic disorder, insomnia, and neuropathic pain.

Status: ACTIVE

Class: Tetracyclic (TeCA), Tricyclic (TCA)

FDA Approval: 1988

Dosage Forms: 10 mg, 25 mg, 50 mg, 75 mg

Biological Half-life: 27-58 hours

Side Effects: Dizziness, dry mouth, constipation, nausea, anxiety, fatigue, blurred vision, vertigo, tachycardia, photosensitivity, sexual dysfunction, headache increased suicide risk

Routes of Administration: Oral, IM, IV

Pregnancy Category: B (US)


Twitter Feed

Gene discovery may explain why Lithium doesn't work for all patients

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology